221 related articles for article (PubMed ID: 35692780)
1. Integrin-Linked Kinase Expression Characterizes the Immunosuppressive Tumor Microenvironment in Colorectal Cancer and Regulates PD-L1 Expression and Immune Cell Cytotoxicity.
Almasabi S; Boyd R; Ahmed AU; Williams BRG
Front Oncol; 2022; 12():836005. PubMed ID: 35692780
[TBL] [Abstract][Full Text] [Related]
2. Cancer-Associated Fibroblasts Promote the Upregulation of PD-L1 Expression Through Akt Phosphorylation in Colorectal Cancer.
Gao Y; Sun Z; Gu J; Li Z; Xu X; Xue C; Li X; Zhao L; Zhou J; Bai C; Han Q; Zhao RC
Front Oncol; 2021; 11():748465. PubMed ID: 34868949
[TBL] [Abstract][Full Text] [Related]
3. Integrin-linked kinase expression in myeloid cells promotes colon tumorigenesis.
Ahmed AU; Almasabi S; Firestein R; Williams BRG
Front Immunol; 2023; 14():1270194. PubMed ID: 38077324
[TBL] [Abstract][Full Text] [Related]
4. CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer.
Peng QH; Wang CH; Chen HM; Zhang RX; Pan ZZ; Lu ZH; Wang GY; Yue X; Huang W; Liu RY
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33579737
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts promote PD-L1 expression in mice cancer cells via secreting CXCL5.
Li Z; Zhou J; Zhang J; Li S; Wang H; Du J
Int J Cancer; 2019 Oct; 145(7):1946-1957. PubMed ID: 30873585
[TBL] [Abstract][Full Text] [Related]
6. A Potential Role for Integrin-Linked Kinase in Colorectal Cancer Growth and Progression via Regulating Senescence and Immunity.
Almasabi S; Ahmed AU; Boyd R; Williams BRG
Front Genet; 2021; 12():638558. PubMed ID: 34163519
[TBL] [Abstract][Full Text] [Related]
7. Periostin deficiency reduces PD-1
Wei T; Wang K; Liu S; Fang Y; Hong Z; Liu Y; Zhang H; Yang C; Ouyang G; Wu T
Cell Rep; 2023 Feb; 42(2):112090. PubMed ID: 36773295
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling.
Roshani Asl E; Rasmi Y; Baradaran B
J Cell Physiol; 2021 Oct; 236(10):7071-7087. PubMed ID: 33821473
[TBL] [Abstract][Full Text] [Related]
9. Integrin-linked kinase modulates lipopolysaccharide- and Helicobacter pylori-induced nuclear factor κB-activated tumor necrosis factor-α production via regulation of p65 serine 536 phosphorylation.
Ahmed AU; Sarvestani ST; Gantier MP; Williams BR; Hannigan GE
J Biol Chem; 2014 Oct; 289(40):27776-93. PubMed ID: 25100717
[TBL] [Abstract][Full Text] [Related]
10. αvβ3-integrin regulates PD-L1 expression and is involved in cancer immune evasion.
Vannini A; Leoni V; Barboni C; Sanapo M; Zaghini A; Malatesta P; Campadelli-Fiume G; Gianni T
Proc Natl Acad Sci U S A; 2019 Oct; 116(40):20141-20150. PubMed ID: 31527243
[TBL] [Abstract][Full Text] [Related]
11. FGFR2 Promotes Expression of PD-L1 in Colorectal Cancer via the JAK/STAT3 Signaling Pathway.
Li P; Huang T; Zou Q; Liu D; Wang Y; Tan X; Wei Y; Qiu H
J Immunol; 2019 May; 202(10):3065-3075. PubMed ID: 30979816
[TBL] [Abstract][Full Text] [Related]
12. The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer.
Imai D; Yoshizumi T; Okano S; Uchiyama H; Ikegami T; Harimoto N; Itoh S; Soejima Y; Aishima S; Oda Y; Maehara Y
Cancer Med; 2017 Jul; 6(7):1614-1626. PubMed ID: 28602029
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation of immune checkpoints in the peripheral blood of breast and colorectal cancer patients.
Elashi AA; Sasidharan Nair V; Taha RZ; Shaath H; Elkord E
Oncoimmunology; 2019; 8(2):e1542918. PubMed ID: 30713804
[TBL] [Abstract][Full Text] [Related]
14. PD-L1-Mediated Immunosuppression in Oral Squamous Cell Carcinoma: Relationship With Macrophage Infiltration and Epithelial to Mesenchymal Transition Markers.
Wu T; Tang C; Tao R; Yong X; Jiang Q; Feng C
Front Immunol; 2021; 12():693881. PubMed ID: 34552581
[TBL] [Abstract][Full Text] [Related]
15. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.
Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD
J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779
[TBL] [Abstract][Full Text] [Related]
16. miRNA-148a-3p Regulates Immunosuppression in DNA Mismatch Repair-Deficient Colorectal Cancer by Targeting PD-L1.
Ashizawa M; Okayama H; Ishigame T; Thar Min AK; Saito K; Ujiie D; Murakami Y; Kikuchi T; Nakayama Y; Noda M; Tada T; Endo H; Fujita S; Sakamoto W; Saito M; Saze Z; Momma T; Ohki S; Mimura K; Kono K
Mol Cancer Res; 2019 Jun; 17(6):1403-1413. PubMed ID: 30872332
[TBL] [Abstract][Full Text] [Related]
17. Immune Regulatory Function of Cancer- Associated Fibroblasts in Non-small Cell Lung Cancer.
Lee H; Hwang M; Jang S; Um SW
Tuberc Respir Dis (Seoul); 2023 Oct; 86(4):304-318. PubMed ID: 37345462
[TBL] [Abstract][Full Text] [Related]
18. PD-1/PD-L1-dependent immune response in colorectal cancer.
Payandeh Z; Khalili S; Somi MH; Mard-Soltani M; Baghbanzadeh A; Hajiasgharzadeh K; Samadi N; Baradaran B
J Cell Physiol; 2020 Jul; 235(7-8):5461-5475. PubMed ID: 31960962
[TBL] [Abstract][Full Text] [Related]
19. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer.
Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141
[TBL] [Abstract][Full Text] [Related]
20. Application of PD-1 Blockade in Cancer Immunotherapy.
Wu X; Gu Z; Chen Y; Chen B; Chen W; Weng L; Liu X
Comput Struct Biotechnol J; 2019; 17():661-674. PubMed ID: 31205619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
